Heron Therapeutics Analyst Ratings
Heron Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Heron Therapeutics (HRTX) rating was a maintained with a price target of $5.00 to $4.00. The current price Heron Therapeutics (HRTX) is trading at is $0.67, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/15/2023 | 497.01% | Needham | $5 → $4 | Maintains | Buy |
| 08/15/2023 | 646.27% | Needham | → $5 | Reiterates | Buy → Buy |
| 07/25/2023 | 646.27% | Needham | $6 → $5 | Maintains | Buy |
| 05/12/2023 | 795.52% | Needham | $7 → $6 | Maintains | Buy |
| 04/21/2023 | 944.78% | Needham | → $7 | Reiterates | → Buy |
| 03/24/2023 | 1392.54% | Evercore ISI Group | $15 → $10 | Maintains | Outperform |
| 03/24/2023 | 944.78% | Needham | $8 → $7 | Maintains | Buy |
| 11/09/2022 | 1094.03% | Needham | $10 → $8 | Maintains | Buy |
| 06/30/2022 | 1392.54% | Needham | $14 → $10 | Maintains | Buy |
| 05/10/2022 | 1989.55% | Needham | $16 → $14 | Maintains | Buy |
| 12/02/2020 | 3482.09% | SVB Leerink | $21 → $24 | Maintains | Outperform |
| 05/27/2020 | 3482.09% | Guggenheim | → $24 | Initiates Coverage On | → Buy |
| 03/02/2020 | 6467.16% | Needham | $48 → $44 | Maintains | Buy |
| 02/20/2020 | 7064.18% | Needham | $50 → $48 | Maintains | Buy |
| 10/03/2019 | 4676.12% | JMP Securities | $38 → $32 | Reiterates | → Market Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/15/2023 | 497.01% | 尼德姆 | 5 美元 → 4 美元 | 维护 | 买 |
| 08/15/2023 | 646.27% | 尼德姆 | → 5 美元 | 重申 | 购买 → 购买 |
| 07/25/2023 | 646.27% | 尼德姆 | 6 美元 → 5 美元 | 维护 | 买 |
| 05/12/2023 | 795.52% | 尼德姆 | 7 美元 → 6 美元 | 维护 | 买 |
| 04/21/2023 | 944.78% | 尼德姆 | → 7 美元 | 重申 | → 购买 |
| 2023 年 3 月 24 日 | 1392.54% | Evercore ISI 集团 | 15 美元 → 10 美元 | 维护 | 跑赢大盘 |
| 2023 年 3 月 24 日 | 944.78% | 尼德姆 | 8 美元 → 7 美元 | 维护 | 买 |
| 11/09/2022 | 1094.03% | 尼德姆 | 10 美元 → 8 美元 | 维护 | 买 |
| 06/30/2022 | 1392.54% | 尼德姆 | 14 美元 → 10 美元 | 维护 | 买 |
| 05/10/2022 | 1989.55% | 尼德姆 | 16 美元 → 14 美元 | 维护 | 买 |
| 12/02/2020 | 3482.09% | SVB Leerink | 21 美元 → 24 美元 | 维护 | 跑赢大盘 |
| 05/27/2020 | 3482.09% | 古根海姆 | → 24 美元 | 启动覆盖范围开启 | → 购买 |
| 03/02/2020 | 6467.16% | 尼德姆 | 48 美元 → 44 美元 | 维护 | 买 |
| 02/20/2020 | 7064.18% | 尼德姆 | 50 美元 → 48 美元 | 维护 | 买 |
| 10/03/2019 | 4676.12% | JMP 证券 | 38 美元 → 32 美元 | 重申 | → 市场跑赢大盘 |
What is the target price for Heron Therapeutics (HRTX)?
Heron Therapeutics（HRTX）的目标价格是多少？
The latest price target for Heron Therapeutics (NASDAQ: HRTX) was reported by Needham on November 15, 2023. The analyst firm set a price target for $4.00 expecting HRTX to rise to within 12 months (a possible 497.01% upside). 7 analyst firms have reported ratings in the last year.
Needham于2023年11月15日公布了Heron Therapeutics（纳斯达克股票代码：HRTX）的最新目标股价。该分析公司将目标股价定为4.00美元，预计HRTX将在12个月内升至12个月内（可能上涨497.01％）。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Heron Therapeutics (HRTX)?
Heron Therapeutics（HRTX）的最新分析师评级是多少？
The latest analyst rating for Heron Therapeutics (NASDAQ: HRTX) was provided by Needham, and Heron Therapeutics maintained their buy rating.
Heron Therapeutics（纳斯达克股票代码：HRTX）的最新分析师评级由Needham提供，Heron Therapeutics维持买入评级。
When is the next analyst rating going to be posted or updated for Heron Therapeutics (HRTX)?
Heron Therapeutics（HRTX）的下一次分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Heron Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Heron Therapeutics was filed on November 15, 2023 so you should expect the next rating to be made available sometime around November 15, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Heron Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Heron Therapeutics的最新评级是在2023年11月15日公布的，因此您应该预计下一个评级将在2024年11月15日左右公布。
Is the Analyst Rating Heron Therapeutics (HRTX) correct?
分析师对Heron Therapeutics（HRTX）的评级是否正确？
While ratings are subjective and will change, the latest Heron Therapeutics (HRTX) rating was a maintained with a price target of $5.00 to $4.00. The current price Heron Therapeutics (HRTX) is trading at is $0.67, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Heron Therapeutics（HRTX）评级维持不变，目标股价为5.00美元至4.00美元。Heron Therapeutics（HRTX）目前的交易价格为0.67美元，超出了分析师的预期区间。
